Company / Assets per Share
Anixa Biosciences Inc Assets per Share History
FY2014-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$0.69
FY2024
5-year range
$0.33 / $1.01
FY2020-FY2024
Trend
-16.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has fluctuated over the past 10 years, ranging from $0.04 in FY2014 to $1.06 in FY2015.
Based on SEC 10-K filings.
0.69 in FY2024 with a 10-year CAGR of +32.0%.
Declined from $1.01 to $0.69 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +15.8%
- 10-Year CAGR
- +32.0%
Key checks
Key Insights
- In FY2024, assets per share decreased 16.0% year-over-year.
- Peak assets per share was recorded in FY2015.
- Lowest assets per share in the period was in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.53 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.69 | -16.0% |
| FY2023 | $0.83 | -18.4% |
| FY2022 | $1.01 | +117.7% |
| FY2020 | $0.46 | +39.7% |
| FY2019 | $0.33 | -14.3% |
| FY2018 | $0.39 | -61.4% |
| FY2017 | $1.01 | +56.1% |
| FY2016 | $0.65 | -39.3% |
| FY2015 | $1.06 | +2355.0% |
| FY2014 | $0.04 | +34.6% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026